Timothy Rolph, Chief Scientific Officer: Akero Therapeutics AKRO Sell · Filed 25/06/12

Trade details

Type: Insider sale
Amount: $127,332
Shares · price: 2,358 sh · $54.00 a share
Held after: 167,363 sh
Stock: Akero Therapeutics AKRO
Person: Timothy RolphChief Scientific Officer
Trade date: 25/06/10
Filed: 25/06/12
Days to filing: 2 days

Sold 1.4% of holdings

Share of holding sold: 1.4%

Akero Therapeutics trades, last 26 weeks

What else happened in Akero Therapeutics around then

Filed or reported within 30 days of the trade day · 25/05/11~25/07/10

Timothy Rolph's recent trades

Timothy RolphChief Scientific Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$527.4K
11,463 sh
$527.4K
Filed 25/10/09
Traded 25/10/07
Timothy RolphChief Scientific Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$48.6K
1,037 sh
$48.6K
Filed 25/10/09
Traded 25/10/07
Timothy RolphChief Scientific Officer
SellAkero Therapeutics
Sell
Akero Therapeutics
AKRO
$23.8K
553 sh
$23.8K
Filed 25/09/12
Traded 25/09/11
Timothy RolphChief Scientific Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$550.6K
12,466 sh
$550.6K
Filed 25/09/10
Traded 25/09/08
Timothy RolphChief Scientific Officer
Sell10b5-1 planAkero Therapeutics
Sell10b5-1 plan
Akero Therapeutics
AKRO
$1,526
34 sh
$1,526
Filed 25/09/10
Traded 25/09/08